Expediting drug development and discovery processes., Improving the efficiency and speed of clinical trials, especially late-stage studies., Increasing the statistical power and accuracy of early-stage clinical investigations., Reducing the number of participants required for clinical studies., Optimizing the design of new clinical trials for better outcomes., Predicting future patient health trajectories and treatment responses., Facilitating academic research into complex disease mechanisms., Aiding healthcare providers in developing personalized treatment strategies., Assisting regulatory bodies in formulating new trial standards., Forecasting disease progression for health insurance management., Supporting public health planning and epidemic control., Reducing operational costs associated with clinical research., Enhancing patient experience in trials by maximizing experimental treatment access.